TITLE

Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening

AUTHOR(S)
Kahesa, Crispin; Mwaiselage, Julius; Wabinga, Henry R.; Ngoma, Twalib; Kalyango, Joan N.; Karamagi, Charles A. S.
PUB. DATE
January 2008
SOURCE
BMC Public Health;2008, Vol. 8, p262
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Cancer of the cervix is the second commonest malignancy in females worldwide and is the leading malignancy among women in Tanzania. Cancer of the cervix has been strongly associated with Human Papilloma Virus (HPV) which is a sexually transmitted disease. However, the role of HIV-1 in the aetiology of cancer of the cervix is less clear. Studies suggest that HPV and HIV-1 infection are synergistic and therefore their dual occurrence may fuel increased incidence of cancer of the cervix and AIDS. We therefore conducted a study to determine the association between cancer of the cervix and HIV-1. Methods: The study was carried out in Ocean Road Cancer Institute, Dar-es-salaam, Tanzania between January and March 2007. A hospital-based case control design was used to study 138 cases and 138 controls. The cases were consenting women 18 years and above with histologically confirmed squamous cell carcinoma of the cervix, while the controls were consenting non-cancer adult women attendants or visitors. The participants were counselled and tested for HIV-1 and interviewed to assess risk factors for cancer of the cervix and HIV-1. Estimation of risk was done by computing odds ratios and confidence intervals. Confounding and interaction between the factors were assessed using logistic regression. Results: HIV-1 prevalence was much higher among the cases (21.0%) than among the controls (11.6%). In logistic regression, HIV-1 was associated with cancer of the cervix (OR = 2.9, 95% CI = 1.4-5.9). Among the casesthe mean age was lower for HIV-1 infected (44.3 years) than HIV-1 uninfected women (54 years, p = 0.0001). Conclusion: HIV-1 infection is associated with invasive cancer of the cervix. Resourceconstrained countries with a high burden of HIV-1 and cervical cancer should adopt a high-risk approach that targets HIV-1 positive women for screening of cervical cancer initially by utilizing HIV/AIDS resources.
ACCESSION #
51486050

 

Related Articles

  • The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. Machalek, Dorothy A.; Grulich, Andrew E.; Hillman, Richard J.; Fengyi Jin; Templeton, David J.; Tabrizi, Sepehr N.; Garland, Suzanne M.; Prestage, Garrett; McCaffery, Kirsten; Howard, Kirsten; Tong, Winnie; Fairley, Christopher K.; Roberts, Jennifer; Farnsworth, Annabelle; Poynten, I. Mary // BMC Public Health;2013, Vol. 13 Issue 1, p1 

    Background The incidence of human papillomavirus (HPV)-associated anal cancer is increasing in men who have sex with men (MSM). Screening for the presumed cancer precursor, high-grade anal squamous intraepithelial lesions (HSIL) in a manner analogous to cervical cancer screening has been...

  • BREAST CANCER AWARENESS.  // Annie's Favorite Crochet;Oct2006, Vol. 24 Issue 5, p18 

    The author comments on breast cancer awareness. According to her, breast cancer is an equalizer that could affect anyone and that breast cancer among women is the second leading cause of cancer death. The author argues that early detection and treatment is the key to surviving this disease. She...

  • Breast Cancer.  // Dolly;Aug2005, Issue 418, p129 

    Provides information on breast cancer in women. Types of breast cancer; Causes of the disease; Risk factors.

  • Identifying and Managing Hereditary Gynecologic Cancers: Don't Gamble with your Patients' Health. Copeland, Karen; Linsner, Carol // Journal of Gynecologic Oncology Nursing;Spring2006, Vol. 16 Issue 2, p11 

    Deals with a study which determined patients at risk for hereditary cancer syndromes, associated cancer risks, available medical management, and genetic testing options. Discussion on hereditary breast and ovarian cancer; Information on lynch syndrome or hereditary nonpolyposis colorectal...

  • Abortion And Miscarriage Don't Increase Breast Cancer Risk.  // RN;Jun2004, Vol. 67 Issue 6, p18 

    Focuses on the absence of a woman's risk of breast cancer from having an abortion or miscarriage. Total number of women involved in the meta-analysis of studies; Comment on the results of a previous research; Comparison between women who had been diagnosed with breast cancer and women who had...

  • Projecting Individualized Absolute Invasive Breast Cancer Risk in Asian and Pacific Islander American Women. Matsuno, Rayna K.; Costantino, Joseph P.; Ziegler, Regina G.; Anderson, Garnet L.; Huilin Li; Pee, David; Gail, Mitchell H. // JNCI: Journal of the National Cancer Institute;Jun2011, Vol. 103 Issue 12, p951 

    Background The Breast Cancer Risk Assessment Tool (BCRAT) of the National Cancer Institute is widely used for estimating absolute risk of invasive breast cancer. However, the absolute risk estimates for Asian and Pacific Islander American (APA) women are based on data from white women. We...

  • Breast cancer in lesbians and bisexual women: systematic review of incidence, prevalence and risk studies. Meads, Catherine; Moore, David // BMC Public Health;2013, Vol. 13 Issue 1, p1 

    Background The UK Parliamentary Enquiry and USA Institute of Medicine state that lesbians may be at a higher risk of breast cancer but there is insufficient information. Lesbians and bisexual (LB) women have behavioural risk-factors at higher rates compared to heterosexuals such as increased...

  • Chemoprevention of Breast Cancer: Recommendations and Rationale: U.S. Preventive Services Task Force.  // Internet Journal of Gynecology & Obstetrics;2003, Vol. 2 Issue 1, p13 

    The U.S. Preventive Services Task Force (USPSTF) recommends against the routine use of tamoxifen or raloxifene for the primary prevention of breast cancer in women at low or average risk for breast cancer. Clinicians should consider both the risk for breast cancer and the risk for adverse...

  • Genetic variants in anti-Mullerian hormone and anti-Mullerian hormone receptor genes and breast cancer risk in Caucasians and African Americans. Hongmei Nan; Dorgan, Joanne F.; Rebbeck, Timothy R. // International Journal of Molecular Epidemiology & Genetics;2014, Vol. 5 Issue 3, p145 

    Anti-Mullerian hormone (AMH) regulates ovarian folliculogenesis by signaling via its receptors, and elevated serum AMH levels are associated with an increased risk of breast cancer. No previous studies have examined the effects of genetic variants in AMH-related genes on breast cancer risk. We...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics